Infection Surveillance Solutions Market Size, Share, And Growth Report 2032

Infection Surveillance Solutions Market Insights

The global Infection Surveillance Solutions market size was worth around USD 672.03 million in 2023 and is predicted to grow to around USD 2185.41 million by 2032 with a compound annual growth rate (CAGR) of roughly 14.00% between 2024 and 2032. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The report covers a forecast and an analysis of the Infection Surveillance Solutions market on a global and regional level.

Request Free Sample

Infection Surveillance Solutions Market: Overview

The programs that help effective management of healthcare-acquired infections in healthcare amenities are recognized as infection surveillance solutions programs. Surveillance is an essential component of effective infection prevention and control programs. The surveillance data decreases the incidences of infections by means of risk factors, executes risk-reduction actions, and monitors the effectiveness of interventions.

The high incidence rate of healthcare-acquired infections is the main concern for governments worldwide apart from being the major factor that is driving the global infection surveillance solutions market. Another major growth driver of the infection surveillance solutions market globally is the high mortality and morbidity rates caused by rising healthcare-acquired infections prevalence. Moreover, the increasing microbe resistance to antibiotics and the growing use of automation in the healthcare setting are also likely to accelerate the global infection surveillance solutions market growth over the forecast time period.

Key Insights

As per the analysis shared by our research analyst, the global Infection Surveillance Solutions Market is estimated to grow annually at a CAGR of around 14% over the forecast period (2024-2032).

In terms of revenue, the global Infection Surveillance Solutions Market size was valued at around USD 672.03 Million in 2023 and is projected to reach USD 2185.41 Million by 2032.

Based on the Device type, Insulin Delivery Devices this segment is the most dominant, accounting for over 91.5% of the market share in 2022. The prominence of insulin delivery devices is driven by technological advancements that enable accurate and precise administration of insulin doses. 

Based on the Animal type, Dogs the canine segment leads the market, holding approximately 55% of the total market share in 2024. This dominance is primarily due to the higher prevalence of diabetes in dogs, particularly among middle-aged and older canines between the ages of 5 and 12 years. 

Based on the End-User, Veterinary Hospitals & Clinics this segment held the largest market share of over 41% in 2024. The dominance is attributed to the increasing number of veterinary hospitals and clinics equipped with updated facilities, serving as primary care providers and major suppliers of medication for diabetic pets. ​

Based on the Region, North America this region held more than 40% of the revenue share of the market in 2024. The dominance is due to high pet ownership rates, advanced veterinary healthcare infrastructure, and increased awareness about pet health management. 

Infection Surveillance Solutions Market: Dynamics

Key Growth Drivers

The infection surveillance solutions market is primarily driven by the increasing incidence of healthcare-associated infections (HAIs) and the growing emphasis on patient safety and infection control. Regulatory mandates and government initiatives to implement infection surveillance programs in hospitals and healthcare facilities further boost market growth. Technological advancements, including artificial intelligence (AI) and data analytics, enable real-time monitoring and early detection of infection outbreaks, enhancing the efficiency of infection control programs. Additionally, the integration of electronic health records (EHRs) with infection surveillance systems facilitates seamless data management and reporting, driving their adoption across healthcare settings.

Restraints

Despite the advantages of infection surveillance solutions, high implementation and maintenance costs can act as significant restraints, particularly for small and medium-sized healthcare facilities. Limited budgets and resource constraints often deter healthcare institutions from investing in advanced infection surveillance systems. Moreover, the lack of skilled professionals with expertise in data analysis and infection control can hinder effective utilization of these solutions. Concerns regarding data privacy and security also pose challenges, as infection surveillance systems involve the collection and storage of sensitive patient information.

Opportunities

The increasing adoption of cloud-based infection surveillance solutions presents significant opportunities for market growth. Cloud platforms offer cost-effective, scalable, and accessible solutions, making them ideal for smaller healthcare facilities and remote locations. Additionally, the growing focus on predictive analytics and artificial intelligence in infection surveillance allows for proactive identification of infection risks, leading to improved patient outcomes. Partnerships between healthcare institutions and technology providers to develop customized surveillance solutions are also expected to create growth opportunities. Furthermore, the rising awareness about infection prevention and control measures in emerging economies is driving demand for advanced infection surveillance systems.

Challenges

One of the major challenges in the infection surveillance solutions market is the complexity of integrating these systems with existing hospital information systems (HIS) and electronic health records (EHRs). Interoperability issues often result in data silos and hinder seamless information exchange, reducing the effectiveness of infection surveillance programs. Additionally, the lack of standardized protocols for infection data reporting and analysis across different healthcare settings can limit the reliability and comparability of surveillance data. Resistance to adopting new technologies due to concerns over workflow disruption and staff training requirements also poses a challenge. Furthermore, the constant evolution of pathogens and the emergence of antimicrobial resistance necessitate continuous updates to surveillance algorithms, adding to operational challenges.

Infection Surveillance Solutions Market: Report Scope

Infection Surveillance Solutions Market: Segmentation

Request Free Sample​

The study provides a decisive view of the infection surveillance solutions market by segmenting it based on product and services, type, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032. 

By product and services, the infection surveillance solutions market includes services and software. The software segment is further bifurcated into on-premises and web-based. The software segment is likely to register the highest growth rate over the forecast time period.

By type, the global infection surveillance solutions market includes surgical site infections, bloodstream infections, urinary tract infections, and others (pulmonary and antimicrobial resistance bacteria). Urinary tract infections are estimated to hold a substantial market share in the upcoming years.

By end-user, the global market includes long-term care centers, hospitals, and others (clinics and ambulatory surgical centers). Hospitals are anticipated to exhibit the highest CAGR along with holding the dominant share of the global infection surveillance solutions market over the forecast time period. This can be attributed to the growing geriatric population, high preference for hospitals by the patients, and efficient treatment of healthcare-associated infections better in hospitals.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.Infection Surveillance Solutions Market: Regional Analysis

The infection surveillance solutions market exhibits distinct regional dynamics, influenced by factors such as healthcare infrastructure, regulatory frameworks, and the prevalence of healthcare-associated infections (HAIs)

Request Free Sample

North America

North America leads the infection surveillance solutions market, primarily due to its advanced healthcare infrastructure and stringent regulatory standards for infection control. The United States, in particular, has a high adoption rate of these solutions, driven by the increasing incidence of HAIs and a strong emphasis on patient safety. The presence of major industry players and the integration of healthcare IT solutions further bolster market growth in this region.

Europe

Europe represents a significant market for infection surveillance solutions, with countries like the United Kingdom, Germany, and France investing in advanced surveillance technologies to combat HAIs. The region's strong focus on patient safety and infection control in healthcare settings contributes to the growing adoption of these solutions.

Asia-Pacific

The Asia-Pacific region is experiencing rapid growth in the infection surveillance solutions market, attributed to the high prevalence of infectious diseases, expanding healthcare services, and a growing emphasis on infection control measures. Countries such as China, Japan, India, and Australia are witnessing increased demand for advanced surveillance technologies in healthcare facilities to monitor and control infections effectively. The region's dense population and rising government healthcare spending further support market expansion.

Latin America

In Latin America, the adoption of infection surveillance solutions is rising as healthcare providers seek to enhance infection control measures and improve patient outcomes. Countries like Brazil and Mexico are at the forefront of implementing advanced surveillance technologies to combat HAIs.

Middle East and Africa

The Middle East and Africa region are witnessing a growing demand for infection surveillance solutions to address the rising incidence of HAIs and ensure patient safety in healthcare facilities. Countries such as Saudi Arabia, the UAE, and South Africa are embracing advanced surveillance technologies for infection control.

Infection Surveillance Solutions Market: Competitive Players

Some major players in the global infection surveillance solutions market are:

• Premier
• Becton
• Dickinson and Company
• Wolters Kluwer
• Gojo Industries
• Atlas Medical Software
• RL Solutions
• Baxter International
• Hygreen
• Deb Group
• Truven Health Analytics

The Global Infection Surveillance Solutions Market is segmented as follows:

Global Infection Surveillance Solutions Market: Product and Services Analysis

• Software
  • On-Premises
  • Web-Based
• Services

Global Infection Surveillance Solutions Market: Type Analysis

• Surgical Site Infections (SSI)
• Blood Stream Infections (BSI)
• Urinary Tract Infections (UTI)
• Others (Pulmonary and antimicrobial resistance bacteria)

Global Infection Surveillance Solutions Market: End-user Analysis

• Long-Term Care Centers
• Hospitals
• Others (Clinics and ambulatory surgical centers)

Global Infection Surveillance Solutions Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa